No Data
imeik technology development (300896.SZ): The growth logic remains the same, and the product expansion strategy outlines the long-term growth blueprint.
In recent years, the medical beauty industry has taken the lead in the capital markets with its high prosperity, and there is a consensus in the market on the long-term positive trend of the medical beauty industry. After going through the dual test of consumer suppression during the pandemic and the gradual recovery of the economy, according to the "China Medical Beauty Industry 2024 Deep Insight Report," 2024 will be a key turning point in the medical beauty field: it will be a new stage where the consumer market transitions from stable recovery to continuous expansion, and it will also be a golden period for the medical beauty industry to improve quality, enhance efficiency, and move towards high-quality development. With the steady recovery of service-oriented consumption, the Chinese medical beauty market is expected to grow by about 10% in 2024.
Stock market midday review: The chinext price index fell by 0.48%. Postal Savings Bank, Bank of Communications, and others hit new highs for the year. The black mythology concept stocks continue to adjust.
As of the midday close, the Shanghai Composite Index fell by 0.04% to 2855.56 points, the Shenzhen Component Index fell by 0.48%, and the chinext price index fell by 0.48%.
Imeik Technology Development's H1 Attributable Profit Rises 16%; Shares Plunge 10%
Imeik Technology Development: Summary of Half-Year Report in 2024.
Imeik Technology Development: Half-year report for the year 2024.
The gross margin of injection products in the solution category has declined, and the imeik technology development's Q2 performance growth rate has dropped to single digits| Speed reading announcement.
①Imeik Technology Development's H1 revenue and net income growth rate slowed down. ②The gross margin of solution injection products has declined, and its proportion in total revenue has further decreased. ③In addition to laying out research and development pipelines for botulinum toxin, GLP-1 drugs, the company is also further expanding in the medical beauty equipment field.
Imeik Technology Development Co.,Ltd.'s (SZSE:300896) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?No Data
, you can go to trade A share there apply and just take 5-10min approve